Email updates

Keep up to date with the latest news and content from Alzheimer's Research & Therapy and BioMed Central.

Commentary

C9orf72 immunohistochemistry in Alzheimer's disease

Tibor Hortobágyi

Author Affiliations

Department of Neuropathology, Institute of Pathology, Medical and Health Science Centre, University of Debrecen, 4032 Debrecen, Nagyerdei krt. 98., Hungary

Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK

Alzheimer's Research & Therapy 2012, 4:37  doi:10.1186/alzrt140


See related research by Satoh et al., http://alzres.com/content/4/4/33

Published: 26 September 2012

Abstract

Mutation in chromosome 9 open reading frame 72 (C9orf72) is a major genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), referred to as C9FTD/ALS. The function of the protein is currently unknown, and the pathomechanism of C9FTD/ALS remains to be elucidated. The study by Satoh and colleagues in the previous issue of Alzheimer's Research & Therapy presents important new findings on C9orf72 protein expression in neurodegenerative disorders along with characterization of C9orf72 antibodies.